Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
- Resource Type
- Article
- Source
- Drug Design, Development & Therapy; Aug2021, Vol. 15, p3463-3473, 11p
- Subject
- Language
- ISSN
- 11778881